$UPB
Upstream Bio, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA
UPB chart
What traders are saying about $UPB
Latest postsUpstream Bio, Inc. news
- FMR LLC and Abigail P. Johnson Reveal 6.9% Ownership Stake in Upstream Bio Inc
Kalkine Media ·
- Upstream Bio (UPB) Options Chain & Prices 2026 $UPB
MarketBeat ·
- Syndax Pharmaceuticals (SNDX) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026
Yahoo Finance ·
- Upstream Bio on Track to Begin Two Phase 3 Verekitug Trials in Q1 2027
Yahoo Finance ·
- Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP
Yahoo Finance ·
- Upstream Bio, Inc. (UPB) Reports Q2 Loss, Tops Revenue Estimates
Yahoo Finance ·
- Upstream Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Progress
Yahoo Finance ·
- Upstream Bio, Inc. (UPB) Upgraded to Buy: What Does It Mean for the Stock?
Yahoo Finance ·
- Is Upstream Bio, Inc. (UPB) a Rising Biotech Opportunity After New Analyst Coverage?
Yahoo Finance ·
- Is Upstream Bio, Inc. (UPB) the Best Low Priced Stocks to Get Rich in 2026?
Yahoo Finance ·
- Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026
Yahoo Finance ·
Upstream Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $2.9M | $2.4M | $2.4M |
| Net income | -$143.4M | -$62.8M | -$20.5M |
| Diluted EPS | $-2.66 | $-5.58 | $-12.95 |
| Total assets (year end) | $353.8M | $481.7M | $117.2M |
| Cash and equivalents (year end) | $101.6M | $325.9M | $25.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Upstream Bio, Inc.
- Ticker
- UPB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 2022626
Frequently asked questions
What exchange is Upstream Bio, Inc. listed on?
Upstream Bio, Inc. trades on the Nasdaq under the ticker symbol UPB.
What industry is Upstream Bio, Inc. in?
Upstream Bio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Upstream Bio, Inc. headquartered?
Upstream Bio, Inc.'s business address on file with the SEC is in Waltham, MA.
When does Upstream Bio, Inc.'s fiscal year end?
Upstream Bio, Inc.'s fiscal year ends on December 31.
How much revenue did Upstream Bio, Inc. report?
Upstream Bio, Inc. reported $2.9M in revenue for calendar year 2025, according to its SEC filings.